In a clinical validation study published on Scientific Reports, UNITY RhD NIPT and Fetal antigen NIPT demonstrated 100% sensitivity, 100% specificity, 99.9% precision with 0.1% no-call rate across ...
MENLO PARK, Calif., Dec. 20, 2024 /PRNewswire/ -- Precision diagnostics company BillionToOne is addressing the longstanding challenges pregnant women face in remote areas. The company's UNITY ...
Last week, readers were most interested in a story about concerns among some clinicians around BillionToOne's Unity NIPT due to false negative results.
MENLO PARK, Calif., Sept. 30, 2022 /PRNewswire/ -- BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the ...
In a clinical validation study published on Scientific Reports, UNITY RhD NIPT and Fetal antigen NIPT demonstrated 100% sensitivity, 100% specificity, 99.9% precision with 0.1% no-call rate across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback